Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
looking for a dynamic and highly motivated PhD student. Research topic Whereas mutations are the driving force for adaptive evolution, many genetic alterations exert negative fitness effects. The effect
-
validate the identified key (epi)genetic molecular and explore their therapeutic potential in vitro and in vivo disease models. Profile The candidate should: have an MSc in Systems Biology, Molecular Biology
-
question: « what makes our brain human ? » (Vanderhaeghen and Polleux, Nat. Rev. Neurosci. 2023). We combine cutting-edge approaches such as pluripotent stem cell models of human corticogenesis, human-mouse
-
Description The laboratory of Neuroimmunology (NIM), headed by Prof. Dr. Emanuela Pasciuto, is a part of the VIB-UAntwerp Center for Molecular Neurology and focuses on multiple aspects of T cells
-
the Guilliams and the Saelens team. Research Project In this research project you will apply in vivo CRISPR screens to study the molecular mechanisms driving liver regeneration. This project is supported by
-
and Saeys teams. In this research project you will develop and apply algorithms to link clinical phenotypes of metastasis to molecular phenotypes in mouse models. It is known that metastases exhibit
-
change in identity in all other cells, often resulting in molecular states that are eerily similar to those observed in diseases. How these intercellular cascades are exactly wired is poorly understood
-
competitive salary package and a stimulating work environment within the VIB-Center for Molecular Neurology. You will do most of your work at Campus Drie Eiken in a dynamic and stimulating
-
Saelens team. Research Project In this research project you will develop probabilistic deep-learning models that automatically extract biological and statistical knowledge from in vivo perturbational omics
-
supported by a Foundation against Cancer (2025 – 2030). We have developed in vivo single-cell CRISPR technologies to screen for dozens of molecular factors in tumor-associated macrophages (TAMs) in vivo. We